Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification

Clinica Chimica Acta

Volumn 426, Issue , 2013, Pages 18-24

  de Antonio, Marta ^a,b   Lupón, Josep ^a,b   Galán, Amparo ^a   Vila, Joan ^c,d   Zamora, Elisabet ^a,b   Urrutia, Agustín ^a,b   Díez, Crisanto ^a,b   Coll, Ramon ^a,b   Altimir, Salvador ^a,b   Bayes Genis, Antoni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Cardiac troponins; Heart failure; Prognosis; Survival

Indexed keywords

TROPONIN I; TROPONIN T;

ARTICLE; CALIBRATION; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ACEI; AIC; AKAIKE INFORMATION CRITERION; ANGIOTENSIN II RECEPTOR BLOCKER; ANGIOTENSIN-CONVERTING ENZYME INHIBITOR; ARB; AREA UNDER THE RECEIVER-OPERATING CHARACTERISTIC CURVE; AUC; BAYESIAN INFORMATION CRITERION; BIC; CARDIAC TROPONINS; EGFR; ESTIMATED GLOMERULAR FILTRATION RATE; HEART FAILURE; HF; HIGH-SENSITIVITY CARDIAC TROPONIN T; HS-CTNT; IDI; INTEGRATED DISCRIMINATION IMPROVEMENT; LEFT VENTRICULAR EJECTION FRACTION; LVEF; N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE; NET RECLASSIFICATION IMPROVEMENT; NRI; NTPROBNP; PROGNOSIS; SC-CTNI; SENSITIVE-CONTEMPORARY CARDIAC TROPONIN I; SURVIVAL;

AGED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 84884344680     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.08.014     Document Type: Article

References (26)

1. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
2. Peacock W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008, 358:2117-2126.
3. Metra M., Nodari S., Parrinello G., et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 2007, 9:776-786.
4. You J.J., Austin P.C., Alter D.A., Ko D.T., Tu J.V. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 2007, 153:462-470.
5. Horwich T.B., Patel J., MacLellan W.R., Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003, 108:833-838.
6. Hudson M.P., O'Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 2004, 147:546-552.
7. Latini R., Masson S., Anand I.S., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
8. Xue Y., Clopton P., Peacock W.F., Maisel A.S. Serial changes in high-sensitivity troponin I predict outcome with decompensated heart failure. Eur J Heart Fail 2011, 13:37-42.
9. Tentzeris I., Jarai R., Farhan S., et al. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 2011, 13:726-733.
10. Pascual-Figal D.A., Manzano-Fernández S., Boronat M., et al. Soluble ST2, high sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011, 13:718-725.
11. Tsutamoto T., Kawahara C., Nishiyama K., et al. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J 2010, 159:63-67.
12. Kawahara C., Tsutamoto T., Sakai H., et al. Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure. Am Heart J 2011, 162:639-645.
13. Jungbauer C.G., Riedlinger J., Buchner S., et al. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-B-type natriuretic peptide. Am Heart J 2011, 161:1031-1037.
14. Masson S., Anand I., Favero C., et al. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Circulation 2012, 125:280-288.
15. De Antonio M., Lupon J., Galan A., Vila J., Urrutia A., Bayes-Genis A. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. Am Heart J 2012, 163:821-828.
16. Zamora E., Lupón J., Vila J., et al. Estimated glomerular filtration rate and prognosis in heart failure: value of the MDRD-4, CDK-EPI, and Cockroft-Gault formulas. J Am Coll Cardiol 2012, 59:1709-1715.
17. Bayes-Genis A., de Antonio M., Galan A., Sanz H., Urrutia A., Cabanes R., et al. Combined use of high sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure. Eur J Heart Fail 2012, 14:32-38.
18. Apple F.S., Ler R., Murakami M. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012, 58:1574-1581.
19. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Vatus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
20. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
21. Pencina M.J., D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004, 23:2109-2123.
22. Pencina M.J., D'Agostino R.B., Steyerberg E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011, 30:11-21.
23. Kociol R.D., Pang P.S., Gheorghiade M., Fonarow G.C., O'Connor C.M., Felker G.M. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010, 56:1071-1078.
24. Ilva T., Lassus J., Siirilä-Waris K., et al. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008, 10:772-779.
25. Eggers K.M., Nygren M., Venge P., Jernberg T., Wikström B.G. High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension. Clin Chim Acta 2011, 412:1582-1588.
26. Apple F.S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012, 58:54-61.